Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Young, Shawquia (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S492000
Reexamination Certificate
active
08003682
ABSTRACT:
Compounds of formula (I):wherein:R1represents an alkyl, cycloalkyl or cycloalkylalkyl group,R2represents a linear or branched (C1-C6)alkyl group,and n represents from 1 to 6.Medicaments.
REFERENCES:
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL http://www.nlm.nih.gov/medlineplus/cancer.html>.
Cancer [online], [retrieved on Jul. 6, 2007]. Retrieved from the internet, URL; http://en.wikipedia.orglwikilCancer.
G. Tarzia, et al., “1-(2-alkanamidoethyl)-6-methoxyindole derivatives: A new class of totent indole melatonin analogues” Journal of Medicinal Chemistry, 1997 vol. 40, No. 13, p. 2003-2010.
M. Mor, et al., “Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands” Bioorganic and Medicinal Chemistry, 2001, vol. 9 No. 4, p. 1045-1057.
International Search Report for PCT/FR2007/001707 of Apr. 1, 2008.
Li, et al.,Drugs of the Future, 2000, 25, 945-957.
Krause, et al.,Society for Neuroscience, 1996, 22, No. 651.19, p. 1400.
Vacas, et al.,J. Pineal Research, 1992, 13, 60-65.
Cagnacci, et al.,J. Pineal Research, 1997, 22, 16-19.
Lagneux, et al.,Life Sciences, 2000, 66, 503-509.
Brydon, et al.,Endocrinology, 2001, 142, 4264-4271.
Bylesjö, et al.,International Journal of Eating Disorders, 1996, 20, 443-446.
Ferrari, et al.,Biol. Psychiatry, 1990, 27, 1007-1020.
Mazzucchelli, et al.,Molecular Brain Research, 1996, 39, 117-126.
Brown,CNS Drugs, 1996, 3, 209-226.
Waldhauser, et al.,Psychopharmacology, 1990, 100, 222-226.
Skene, et al.,Brain Research, 1990, 528, 170-174.
Monteleone, et al.,Schizophrenia Research, 1992, 7, 77-84.
Mc Intyre, et al.,Journal of Affective Disorders, 1987, 12, 203-206.
Erlich, et al.,J. Neurosurg., 1985, 63, 321-341.
Maurizi,Medical Hypotheses, 1988, 27, 271-276.
Kopp, et al.,Behavioural Pharmacology, 1999, 10, 73-83.
Kopp, et al.,Neuorpharmacology, 2000, 39, 1865-1871.
Fanteck, et al.,Exp. Brain Res., 1995, 107, 321-325.
Rasmussen, et al.,Endocrinology, 1999, 140, 1009-1012.
Armstrong, et al.,Medical Hypotheses, 1991, 34, 300-309.
O'Brien, et al.,Clinical Endocrinology, 1986, 24, 359-364.
Motilva, et al.,Current Pharmaceutical Design, 2001, 7, 909-931.
Tamarkin, et al.,Science, 1985, 227, 714-720.
Chemineau, et al.,Rec. Med. Vet., 1991, 167, 227-239.
Xu, et al.,Drug Development Research, 1996, 39, 167-173.
Regrigny, et al.,Am. J. Physiol., 1998, 275, 139-144.
Stankov, et al.,Neuroscience, 1993, 52, 459-468.
Leone, et al.,Cephalalgia, 1996, 16, 494-496.
Brun, et al.,Cephalalgia, 1995, 15, 136-139.
Ying, et al.,Eur. J. of Pharmacology, 1993, 246, 89-96.
Laudon, et al.,Journal of Clinical Endocrinology and Metabolism, 1996, 81, 1336-1342.
Lissoni, et al.,British Journal of Cancer, 1996, 74, 1466-1468.
Audinot Valerie
Babonneau Vincent
Boutin Jean Albert
Caignard Daniel-Henri
Delagrange Philippe
Hueschen and Sage
Les Laboratories Servier
Young Shawquia
LandOfFree
Indole compounds, a process for their preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole compounds, a process for their preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole compounds, a process for their preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699949